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Edited by Thomas L. JamesAbstract Xenopus laevis nucleoplasmin is a molecular chaper-
one that mediates sperm decondensation and nucleosome
assembly. Nucleoplasmin has three acidic tracts (A1, A2 and
A3) and until recent years the long polyglutamic tract A2 was
thought to be the binding site for basic proteins. However, the
latest publications in this ﬁeld show that neither A2 nor A3 is
indispensable for histone and sperm-speciﬁc protein binding. In
this work, we show that the mutation of only four acidic amino
acid residues of the small A1 tract drastically reduces nucleo-
plasmin decondensing activity, pointing out this region as the
potential binding site for sperm proteins.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Nucleoplasmin; Nuclear chaperone;
Sperm chromatin remodeling1. Introduction
Xenopus laevis nucleoplasmin was the ﬁrst molecular chap-
erone described [1]. Nucleoplasmin is an acidic and thermo-
stable protein that associates into pentamers [2] and
participates in both the sperm DNA decondensing and nu-
cleosome assembly that occurs after fertilization [3]. The
amino acid sequence of nucleoplasmin, deduced from two
slightly diﬀerent cDNA clones [4,5], shows the presence of
three acidic tracts (A1, A2 and A3) in the protein, A2 being the
longest one. A2 and A3 are found in the tail domain of nu-
cleoplasmin, while A1 is found in its core domain (Fig. 1A).
Although it has been traditionally accepted that nucleoplasmin
would interact with basic proteins through its acidic tracts, the
latest publications in the ﬁeld show how nucleoplasmin can
still bind to histones and protamines not only in the absence of
the acidic tract A3 but also, more surprisingly, in the absence
of the long A2 tract [6–9]. However, to date no experimental* Corresponding author. Fax: +93-4010978.
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Abbreviations: r-NP, recombinant nucleoplasmin; (-A1), mutation in
the acidic tract A1; AU–PAGE, acetic acid-urea polyacrylamide gel
electrophoresis; SDS–PAGE, sodium dodecyl sulfate–polyacrylamide
gel electrophoresis
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.07.095data have been provided with regard to the role of the small
acidic tract A1. In this paper, we show how the change of four
of the acidic amino acid residues of the A1 tract drastically
reduces the sperm decondensing activity of nucleoplasmin even
in the presence of the acidic tracts A2 and A3, thus providing
direct evidence of the importance of the A1 tract in nucleo-
plasmin function.2. Materials and methods
2.1. Recombinant proteins
Recombinant nucleoplasmins r-NP, r-NP142 and r-NP121, have
been obtained from the B€urglin’s cDNA [4] as previously described [7].
r-NP represents the full-length recombinant version of nucleoplasmin
and contains the three acidic parts of the molecule (A1, A2 and A3).
r-NP142 is a C-terminal deleted form, extending from amino acids 1 to
142, which contains the main acidic tract, A2, at the C-terminus of the
protein. Finally, r-NP121 (from amino acids 1 to 121) represents the
core domain of nucleoplasmin and lacks both the acidic tracts A2 and
A3. All the mutations in the acidic tract A1 (-A1) (Fig. 1B) have been
produced by site-directed mutagenesis using the QuickChange Site-
Directed Mutagenesis kit (Stratagene) and have been expressed and
puriﬁed in the same way as their non-mutated counterparts. Protein
concentration has been determined from the absorbance at 276 nm [7].
2.2. Isolation of sperm nuclei and protamine puriﬁcation
Sperm cells from Dicentrarchus labrax (sea bass) and its protamine
have been prepared as in [7]. Sperm cells from X. laevis have been
obtained and treated as in [10]. X. laevis sperm nuclei are condensed by
ﬁve diﬀerent sperm speciﬁc basic proteins (SP2-6), which are found
coexisting with histones H3 and H4 and small amounts of histones
H2A and H2B. Instead, D. labrax sperm nuclei are condensed by a
single protamine very similar to the protamines from other amphibia,
which also possess nucleoplasmin. Thus, D. labrax sperm has been
accepted as a simple model to test nucleoplasmin activity [7].
2.3. Sperm chromatin decondensation assay
In a ﬁrst set of assays, 2 ll aliquots containing 3.6 105 D. labrax or
2 105 X. laevis demembranated sperm nuclei in EM buﬀer (0.1 M
KCl, 2 mMMgCl2 and 10 mM Tris–HCl, pH 7.4) were mixed with 2 ll
of 0.1 mg/ml Hoechst 33258 in EM buﬀer and 5 ll of 5.8 105 M
nucleoplasmin in EM buﬀer, and the sperm nuclear swelling eﬀect was
monitored by ﬂuorescence microscopy (k ¼ 360 nm). In a parallel as-
say, 2 106 D. labrax demembranated sperm nuclei were incubated
with 70 ll of either EM buﬀer or 5.8 105 M nucleoplasmin in EM
buﬀer for 30 min at room temperature with gentle agitation. Samples
were centrifuged for 5 min at 16 000 g in an Eppendorf microfuge
and the supernatants were extensively dialyzed against water, using
Slide-A-lyzer mini dialysis units (Pierce), and speed-vac dried. Then the
supernatants were analyzed electrophoretically using acetic acid-urea
polyacrylamide gel electrophoresis (AU–PAGE) in order to check theblished by Elsevier B.V. All rights reserved.
Fig. 1. (-A1) nucleoplasmin mutants. (A) Schematic representation of
nucleoplasmin monomer. The acidic tract A1 is found in the core
domain of the protein in an external loop between b-sheets 2 and 3.
The acidic tracts A2 and A3 are found in the tail domain of the pro-
tein. (B) Scheme of the loop mentioned in A showing the amino acid
residues that have been mutated to obtain the (-A1) mutants. (C) 15%
SDS–PAGE of the mutant (-A1) forms used in this work. (+) Samples
boiled or ()) not boiled prior to loading onto the gel. The asterisks
show the oligomeric forms of nucleoplasmin. The arrowhead shows a
truncated nucleoplasmin form [13,14] that copuriﬁes with the main
form. Molecular weight markers (MWM) are shown in kilodaltons.
(D) Sedimentation velocity analysis of r-NP121(-A1).
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This experiment was always carried out by duplicate.
In order to check the eﬀect of nucleoplasmin concentration in these
assays, we performed a second set of similar assays but using in-
creasing concentrations of the diﬀerent nucleoplasmin (-A1) mutant
forms. Thus, concentrations up to 3 have been evaluated.2.4. Miscellaneous methods
Sedimentation velocity analysis, AU–PAGE and sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) were carried
out as in [7]. Comparison of the electrophoretic bands has been carried
out by densitometry.3. Results
3.1. Nucleoplasmin (-A1) mutants are thermostable and
pentameric
The acidic tract A1 is found within the nucleoplasmin core
in an external loop between b-sheets 2 and 3 [6]. In order to
eliminate the acidity of this tract without eliminating the polar
nature of the loop, we have mutated only four of the acid
residues of A1 and have substituted them for four glutamine
residues while maintaining the other polar residues of the loop
(Fig. 1B). We have mutated the A1 tract not only in the full r-
NP form but also in two deletion mutants obtained previously
in our laboratory: r-NP142 (which lacks the acidic tract A3)
and r-NP121 (which lacks both A2 and A3 tracts) [7], ob-
taining thus the forms r-NP(-A1), r-NP142(-A1) and r-
NP121(-A1).
All the (-A1) mutants were recovered in the thermostable
fraction during the puriﬁcation procedure and retain their
pentamerizing ability as shown in Fig. 1C. Thus, as typically
happens with nucleoplasmin, when the (-A1) forms are loaded
without boiling onto a SDS–PAGE, a high molecular weight
band corresponding to the oligomer can be observed (see as-
terisks in Fig. 1C). However, in the case of r-NP121(-A1) the
band corresponding to the oligomer does not present the same
electrophoretic migration as its counterpart form r-NP121. In
order to check whether or not r-NP121(-A1) exists as a pen-
tamer in solution, we carried out a sedimentation velocity
analysis of this form. As shown in Fig. 1D, r-NP121(-A1)
presents a sedimentation coeﬃcient of about 4.75 S, in perfect
agreement with the 4.8 S value published for the r-NP121
pentamer [7].
3.2. Mutation of the A1 acidic tract drastically reduces
nucleoplasmin protamine removal and sperm nuclear
swelling ability
In order to test if the (-A1) mutation could aﬀect the sperm
decondensing ability of nucleoplasmin, we performed the
sperm chromatin decondensation assay described above. For
these experiments, we have used the sperm of the ﬁsh D. labrax
as a system because of its simpler chromosomal protein com-
position (only one protamine present) when compared to
Xenopus sperm (see also Section 2).
Figs. 2–4 show, respectively, the comparison of r-NP(-A1),
r-NP142(-A1) and r-NP121(-A1) with their non-mutated
counterparts regarding both their sperm nuclei swelling ability
and their protamine removal ability. When equimolar 1
concentrations of control and mutant nucleoplasmins are used,
it can be observed that the (-A1) mutation decreases nucleo-
plasmin activity in the three forms although to diﬀerent extent.
r-NP142(-A1) is less aﬀected, with a decrease in its protamine
removal activity of about 40% (Fig. 3A–D), however, r-NP-
(-A1) and r-NP121(-A1) are dramatically impaired, with a
decrease of about 80% and 90%, respectively, in their prot-
amine removal activity (Figs. 2A–D and 4A–D). There is also
a time eﬀect observed during the monitoring by ﬂuorescence
microscopy. Thus, r-NP(-A1) and r-NP121(-A1) mutants
Fig. 2. Comparison of the activity of r-NP and r-NP(-A1). Fluores-
cence micrographs of D. labrax sperm nuclei incubated with either EM
buﬀer, control assay (A), or with an equimolar 1x concentration of r-
NP (B) or r-NP(-A1) (C) in EM buﬀer. The bar corresponds to 10 lm.
(D) 15% AU–PAGE of the protamines removed after the incubation of
the sperm nuclei with EM buﬀer (lanes 3 and 30), or r-NP (lanes 4 and
40) and r-NP(-A1) (lanes 5 and 50) at equimolar 1 concentrations.
Lanes 1, 2 and 6 correspond to electrophoretic controls of r-NP (1), r-
NP(-A1) (2) and protamine (6). The arrowhead shows a fast mobility
band that is already found in the r-NP(-A1) sample. (E) Fluorescence
micrograph of D. labrax sperm nuclei incubated with r-NP(-A1) at a
3 concentration. The amount of protamine removed when r-NP(-A1)
3 is used in the incubation (inset, right) is compared with the amount
removed when control r-NP 1 is used (inset, left). The arrowhead
shows a fast mobility band that is already found in the r-NP(-A1)
sample.
Fig. 3. Comparison of the activity of r-NP142 and r-NP142(-A1).
Fluorescence micrographs of D. labrax sperm nuclei incubated with
either EM buﬀer, control assay (A), or with an equimolar 1 con-
centration of r-NP142 (B) or r-NP142(-A1) (C) in EM buﬀer. (D) 15%
AU–PAGE of the protamines removed after the incubation of the
sperm nuclei with EM buﬀer (lanes 3 and 30), r-NP142 (lanes 4 and 40)
or r-NP142(-A1) (lanes 5 and 50) at equimolar 1 concentrations.
Lanes 1, 2 and 6 correspond to electrophoretic controls of r-NP142 (1),
r-NP142(-A1) (2) and protamine (6). The bar corresponds to 10 lm.
(E) Fluorescence micrograph of D. labrax sperm nuclei incubated with
r-NP142(-A1) at a 3 concentration. (F) The amount of protamine
removed by control r-NP142 at 1 concentration (lane a) is compared
with the amount removed by r-NP142(-A1) at 1, 2 and 3 con-
centrations (lanes b, c and d, respectively).
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their non-mutated couterparts and they do it just to a very
limited extent. r-NP142(-A1) is less aﬀected both in the time
needed (5–7 min of delay regarding r-NP142) and the extent of
nuclear swelling achieved.
In a set of experiments carried out to test the eﬀect of nu-
cleoplasmin concentration, we observed that while both the
sperm decondensing ability and the protein removal activity
could be soon matched with the control when increasing con-
centrations of r-NP142(-A1) were used, this was not the case
with r-NP(-A1) and r-NP121(-A1). Thus, when the concentra-
tion of r-NP142(-A1) was increased 3-fold that of the control (r-
NP142), the amount of protamine removed by both proteins
was the same (Fig. 3F). Likewise, during the ﬂuorescence mi-
croscopy assays, r-NP142(-A1) 3 showed the same activity as
control r-NP142 1 both in the extent of decondensation and in
the time needed to achieve it (Fig. 3E). However, with r-NP-
(-A1) and r-NP121(-A1) only a certain increase in the degree of
sperm swelling and protamine removal is observed upon in-
crease of the concentration. However, it does not match that of
their respective control activity (see Figs. 2E and 4E).
When the sperm decondensing assay was carried out using
X. laevis sperm nuclei, a similar sperm swelling activity be-
havior was observed, i.e., the (-A1) mutation aﬀects mostly the
decondensing sperm nuclei activity of r-NP and r-NP121,while r-NP142 is little aﬀected (Fig. 5). Sperm nuclei incubated
with r-NP(-A1) (Fig. 5C) and r-NP121(-A1) (Fig. 5G) retain a
similar appearance as that of control nuclei (Fig. 5A) while the
nuclei incubated with r-NP142(-A1) (Fig. 5E) are longer and
thicker, highly resembling the nuclei that had been incubated
with the corresponding control nucleoplasmin form (Fig. 5D).
It is also worth noting that the swelling activity of r-NP
(Fig. 5B) and r-NP121 (Fig. 5F) is lower than that of r-NP142
forms (Fig. 5D-E). Similar results have been reported with r-
NP obtained from the Dingwall’s clone [11], although these
authors only observed noticeable decondensing activity with
the equivalent form to our r-NP142 (which possess the acidic
tract A2 virtually at the end of the molecule) but not with the
equivalents to our r-NP and r-NP121 forms. The diﬀerences
observed between both studies are only quantitative but not
qualitative and may be due to the diﬀerent experimental con-
ditions or to the nature of the nucleoplasmin clone used.4. Discussion
Contrary to what was expected, a number of articles have
appeared in recent years which provide evidence that the long
Fig. 5. Decondensing activity of (-A1) nucleoplasmin mutants on X.
laevis sperm nuclei. Fluorescence micrographs of X. laevis sperm nuclei
incubated with either EM buﬀer (A), or with equimolar concentrations
of r-NP (B), r-NP(-A1) (C), r-NP142 (D), r-NP142(-A1) (E), r-NP121
(F) and r-NP121(-A1) (G). The bar corresponds to 10 lm.
Fig. 4. Comparison of the activity of r-NP121 and r-NP121(-A1).
Fluorescence micrographs of D. labrax sperm nuclei incubated with
either EM buﬀer, control assay (A), or with an equimolar 1 con-
centration of r-NP121 (B) or r-NP121(-A1) (C) in EM buﬀer. The bar
corresponds to 10 lm. (D) 15% AU–PAGE of the protamines removed
after the incubation of the sperm nuclei with EM buﬀer (lanes 3 and
30), or r-NP121 (lanes 4 and 40) and r-NP121(-A1) (lanes 5 and 50) at
equimolar 1x concentrations. Lanes 1, 2 and 6 correspond to electro-
phoretic controls of r-NP121 (1), r-NP121(-A1) (2) and protamine (6).
(E) Fluorescence micrograph of D. labrax sperm nuclei incubated with
r-NP121(-A1) at a 3 concentration. The amount of protamine re-
moved when r-NP121(-A1) 3 is used in the incubation (inset, right) is
compared with the amount removed when control r-NP121 1 is used
(inset, left).
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histone binding nor for sperm-speciﬁc protein binding. The
same is true for the A3 acidic tract. The recently crystallized
nucleoplasmin core domain obtained from the Dingwall’s
clone only presents one small acidic tract (A1 tract) and can
still bind to histones [6]. Similarly, an equivalent form ex-
pressed from the B€urglin’s clone was also able to bind to hi-
stones [8]. Furthermore, the core domain of the
nucleoplasmin-like protein from Drosophila melanogaster
(dNLP), which has a crystal structure very similar to the nu-
cleoplasmin pentamer, can also bind to histones in spite of
containing only the A1 acidic tract [12]. Also, the sperm
chromatin decondensing activity of nucleoplasmin can be
performed in the absence of both A2 and A3 tracts, although
the A2 tract seems to enhance this activity [7].
These results suggest that the short A1 acidic tract of nu-
cleoplasmin may be much more important for the binding to
basic proteins than it had been previously anticipated. How-
ever, no direct proof has ever been provided for the involve-
ment of A1 in this function. Our work represents the ﬁrst
attempt to directly answer this question and substantiates the
experimental evidence regarding the implication of the acidic
tract A1 in the binding and removal of sperm-speciﬁc proteins
from DNA that results in the sperm nuclei decondensation.
We have observed that the mutation of four amino acid resi-
dues of the A1 tract (-A1 mutation) drastically reduces not
only the decondensing activity of r-NP121 (which possess no
other acidic tract but A1) but also reduces that of the full-
length form r-NP (which still has the acidic tracts A2 and A3).Hence, r-NP(-A1) and r-NP121(-A1) achieve a lower degree of
nuclear swelling than their control counterparts even if 3-fold
concentrations are used. The decrease in the sperm-basic
protein removal activity does not seem to be due to global
changes in the conformation of the molecule, since the (-A1)
mutation has no inﬂuence in either the thermostability of the
protein or its pentameric conformation.
It has been proposed that electrostatic interactions at the C-
terminal domain of nucleoplasmin can modulate its chromatin
decondensing activity by a mechanism that involves the
shielding of the A2 polyglutamic tract by the positively
charged amino acids at the C-terminal end of the molecule [11].
This would be in agreement with the ﬁnding that r-NP(-A1)
activity is drastically diminished in spite of the presence of the
A2 acidic tract. It has been further proposed [11] that phos-
phorylation would modify these interactions and expose the
A2 polyglutamic region enhancing nucleoplasmin activity.
Again, this is also consistent with our observation that r-
NP142(-A1) is the least aﬀected of the (-A1) mutants, as the A2
tract is fully exposed in this mutant.
The acidic tract A1 is found in the nucleoplasmin core in the
ﬂexible loop connecting strands b2 and b3 that is found in the
distal face of the pentamer. Although the A1 tract is variable in
the nucleoplasmin family, containing from four to twelve
acidic amino acid residues, this acidic feature is conserved in
this protein family [6,12], adding to the importance of this
L. Salvany et al. / FEBS Letters 576 (2004) 353–357 357region. It has recently been proposed [9] that phosphorylation
of certain amino acid residues, in conjunction with the A1
tracts, could generate a strong localized negative potential at
the distal face of the nucleoplasmin pentamer, which could be
a good candidate for the binding site of sperm speciﬁc nuclear
basic proteins. We have now provided direct evidence that
mutation of the A1 region strongly aﬀects the decondensing
activity of nucleoplasmin. Unpublished results from our lab-
oratory with a r-NP142 mutant, that is not able to penta-
merize, also indicate that the integrity of the nucleoplasmin
pentamer is needed to successfully carry out the protamine
removal activity. The non-pentamerizing r-NP142 mutant has
a very limited capacity to swell the sperm nuclei when an assay
similar to that of Fig. 3 is carried out.
Although the results described in this paper can help to elu-
cidate the working mechanism of nucleoplasmin, there are still
many questions that remain unanswered. For instance, there is
no agreement yet regarding the stoichiometry of the complexes
formed between nucleoplasmin and basic proteins; we still do
not know for certain which amino acid residues of nucleoplas-
min are phosphorylated during the in vivo activation of this
protein; andwe do not even know if there is a unique or diﬀerent
binding sites for sperm proteins and histones. In this regard, we
are currently investigating how the mutation of the small A1
acidic tract can aﬀect nucleoplasmin binding to histones.
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